STRUCTURED LITERATURE REVIEW OF THE PREVALENCE OF MICROSATELLITE INSTABILITY HIGH (MSI-H) AND DEFICIENT MISMATCH REPAIR (DMMR) AMONG SOLID TUMORS

被引:0
|
作者
Lorenzi, M. [1 ]
Amonkar, M. [1 ]
Zhang, J. [1 ]
Mehta, S. [1 ]
Liaw, K. [2 ]
机构
[1] Precis Xtract, Oakland, CA USA
[2] Merck & Co Inc, N Wales, PA USA
关键词
D O I
10.1016/j.jval.2018.09.135
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN53
引用
收藏
页码:S22 / S23
页数:3
相关论文
共 50 条
  • [1] Epidemiology of Microsatellite Instability High (MSI-H) and Deficient Mismatch Repair (dMMR) in Solid Tumors: A Structured Literature Review
    Lorenzi, Maria
    Amonkar, Mayur
    Zhang, Jacky
    Mehta, Shivani
    Liaw, Kai-Li
    [J]. JOURNAL OF ONCOLOGY, 2020, 2020
  • [2] FREQUENCY OF AND TESTING PATTERNS FOR MICROSATELLITE INSTABILITY HIGH (MSI-H) AND DEFICIENT MISMATCH REPAIR (DMMR) AMONG SOLID TUMORS IN A US COMMUNITY ONCOLOGY SETTING
    Chase, M.
    Vasudevan, A.
    Amonkar, M.
    Myer, N.
    Wang, T.
    Prabhu, V
    Turzhitsky, V
    Spira, A.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S452 - S452
  • [3] Structured literature review (SLR) and meta-analyses of the prevalence of microsatellite instability high (MSI-H) and deficient mismatch repair (dMMR) in gastric, colorectal, and esophageal cancers.
    Amonkar, Mayur
    Lorenzi, Maria
    Zhang, Jacky
    Mehta, Shivani
    Liaw, Kai-Li
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] SYSTEMATIC AND STRUCTURED REVIEWS OF THE DISEASE BURDEN IN PATIENTS WITH MICROSATELLITE INSTABILITY HIGH (MSI-H) OR MISMATCH REPAIR DEFICIENT (DMMR) COLORECTAL CANCER (CRC)
    Amonkar, M.
    Chase, M.
    Takyar, J.
    Sharma, S.
    [J]. VALUE IN HEALTH, 2021, 24 : S24 - S24
  • [5] Pembrolizumab in microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) advanced solid tumors: An update of the phase II KEYNOTE-158 trial
    Maio, M.
    Ascierto, P. A.
    Motola Kuba, D.
    Penel, N.
    Cassier, P. A.
    Bariani, G. M.
    De Jesus-Acosta, A.
    Doi, T.
    Longo Munoz, F.
    Miller, W. H.
    Oh, D-Y.
    Gottfried, M.
    Yao, L.
    Jin, F. J.
    Gozman, A.
    Marabelle, A.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S589 - S590
  • [6] Clinicopathological and genomic characteristics of DNA Mismatch Repair-Deficient (dMMR) and microsatellite instability-high (MSI-H) resected gastric adenocarcinoma
    Zhou, J.
    Liang, B.
    Yin, M.
    Zhang, H.
    Liu, F.
    Dong, L.
    Zhang, B.
    Xu, Y.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S921 - S922
  • [7] Literature review and meta-analyses of the prevalence of microsatellite instability high (MSI-H) and deficient mismatch repair (dMMR) for colorectal (CRC), gastric (GC), endometrial (EC) and ovarian cancers (OC) in Chinese population
    Liu, Xiaoqiao
    Fan, Jiaqi
    Liaw, Kai-Li
    Xu, Mo
    Zhou, Yu
    Amonkar, Mayur
    Zeng, Gefei
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [8] Neoadjuvant nivolumab plus ipilimumab in microsatellite instability-high (MSI-H)/deficient mismatch repair (dMMR) rectal tumors: ECOG-ACRIN EA2201
    Ciombor, K. K.
    Hong, S.
    Eng, C.
    Yao, X.
    You, N.
    Das, P.
    Chakravarthy, A.
    O'Dwyer, P. J.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S104 - S104
  • [9] The clinical courses of solid tumors with microsatellite instability-high (MSI-H)
    Inagaki, Yuichiro
    Ohara, Fumiya
    Yokota, Hirofumi
    Takeuchi, Yuki
    Sawa, Hitomi
    Miyao, Kotaro
    Takashi, Seki
    Arima, Junko
    Yoneyama, Eiji
    Sawa, Masashi
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S344 - S344
  • [10] A single-arm, phase II, multicenter study of iparomlimab (QL1604) in patients (pts) with unresectable/metastatic deficient mismatch repair (dMMR)/microsatellite instability high (MSI-H) solid tumors
    Guo, W.
    Bi, F.
    Dong, J.
    Jin, C.
    Niu, Z.
    Wang, Y.
    Sun, M.
    Wang, T.
    Yu, D.
    He, Y.
    Zhang, R.
    Yin, X.
    Feng, W.
    Zhang, M.
    Li, L.
    Zhang, B.
    Kang, X.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1511 - S1511